Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
Titel:
Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors
Auteur:
Di Federico, A. Hong, L. Elkrief, A. Thummalapalli, R. Cooper, A.J. Ricciuti, B. Digumarthy, S. Alessi, J.V. Gogia, P. Pecci, F. Makarem, M. Gandhi, M.M. Garbo, E. Saini, A. De Giglio, A. Favorito, V. Scalera, S. Cipriani, L. Marinelli, D. Haradon, D. Nguyen, T. Haradon, J. Voligny, E. Vaz, V. Gelsomino, F. Sperandi, F. Melotti, B. Ladanyi, M. Zhang, J. Gibbons, D.L. Heymach, J.V. Nishino, M. Lindsay, J. Rodig, S.J. Pfaff, K. Sholl, L.M. Wang, X. Johnson, B.E. Jänne, P.A. Rekhtman, N. Maugeri-Saccà, M. Heist, R.S. Ardizzoni, A. Awad, M.M. Arbour, K.C. Schoenfeld, A.J. Vokes, N.I. Luo, J.